{"id":"a2","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":{"setId":"4baa5c95-79a6-4ae8-a8c4-1edbf308f92c","title":"VIREX (ADENOVIREN NOSODE, ASCLEPIAS TUBEROSA, CALCAREA ARSENICICA, CAMPHORA, COXSACKIE A2 NOSODE, COXSACKIE A3 NOSODE, COXSACKIE A4 NOSODE, COXSACKIE A5 NOSODE, COXSACKIE A7 NOSODE, COXSACKIE B1 NOSODE, COXSACKIE B3 NOSODE, COXSACKIE B4 NOSODE, COXSACKIE B5 NOSODE, CYTOMEGALOVIRUS NOSODE, ECHINACEA PURPUREA, EPSTEIN-BARR VIRUS NOSODE, EUPHRASIA OFFICINALIS, INFLUENZINUM, LAC VACCINUM, MORBILLINUM, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, THUJA OCCIDENTALIS, TRIFOLIUM PRATENSE, VARIOLINUM) SPRAY [NUTRITIONAL SPECIALTIES, INC.]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action increases the levels of these neurotransmitters in the brain, which can help improve mood and reduce symptoms of depression. A2 is a norepinephrine-dopamine reuptake inhibitor (NDRIs).","oneSentence":"A2 is a medication that works by inhibiting the reuptake of norepinephrine, serotonin, and dopamine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:28:04.375Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT06925737","phase":"PHASE3","title":"A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":"Prostate Cancer, Prostatic Neoplasms","enrollment":1440},{"nctId":"NCT07324096","phase":"NA","title":"A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-03-24","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":100},{"nctId":"NCT06547372","phase":"NA","title":"Dietary Intervention on Atopy","status":"RECRUITING","sponsor":"National University of Singapore","startDate":"2024-05-10","conditions":"Atopic Dermatitis, Atopic, Allergic Diseases","enrollment":110},{"nctId":"NCT05564377","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-04-07","conditions":"Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8","enrollment":2900},{"nctId":"NCT05531565","phase":"PHASE2, PHASE3","title":"A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus","status":"RECRUITING","sponsor":"Biogen","startDate":"2022-09-13","conditions":"Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus","enrollment":450},{"nctId":"NCT07495423","phase":"NA","title":"Exploring the Efficacy of a Breathing Training Intervention in Patients With Emotionally Regulated Sleep Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-07-11","conditions":"Sleep Disorder (Disorder), Mood Disorders","enrollment":188},{"nctId":"NCT07210515","phase":"PHASE3","title":"Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)","status":"RECRUITING","sponsor":"Ambros Therapeutics, Inc.","startDate":"2026-03","conditions":"Complex Regional Pain Syndrome Type I","enrollment":270},{"nctId":"NCT06980428","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-05-27","conditions":"Healthy Participants, Dyslipidemia","enrollment":136},{"nctId":"NCT00410241","phase":"","title":"ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2007-01-05","conditions":"Healthy Volunteers, Atherosclerotic Heart Disease","enrollment":1665},{"nctId":"NCT01187368","phase":"NA","title":"Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System","status":"SUSPENDED","sponsor":"Evaheart, Inc.","startDate":"2020-03-31","conditions":"Heart Failure","enrollment":399},{"nctId":"NCT07290283","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-10","conditions":"Healthy Participants","enrollment":176},{"nctId":"NCT05651919","phase":"","title":"PBMC as Biomarkers of Diabetic Cardiomyopathy","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-05-23","conditions":"Type 2 Diabetes, Metabolic Syndrome, Heart Failure With Preserved Ejection Fraction","enrollment":175},{"nctId":"NCT06637371","phase":"PHASE1","title":"A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-10-16","conditions":"Asthma","enrollment":124},{"nctId":"NCT06554665","phase":"NA","title":"Powering Up Stroke Rehabilitation Through HIIT","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-08-20","conditions":"Stroke","enrollment":66},{"nctId":"NCT07221357","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-12-31","conditions":"Untreated, Unresectable, or Metastatic Colorectal Cancer","enrollment":990},{"nctId":"NCT05099003","phase":"PHASE1, PHASE2","title":"A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-05-31","conditions":"Malignant Glioma","enrollment":132},{"nctId":"NCT04236388","phase":"NA","title":"Short Term Ketone Supplementation and Cardiometabolic Health","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2020-10-02","conditions":"Cardiovascular Risk Factor","enrollment":11},{"nctId":"NCT07493772","phase":"NA","title":"Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania","status":"NOT_YET_RECRUITING","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2026-05-01","conditions":"Anemia","enrollment":1200},{"nctId":"NCT06863272","phase":"PHASE1, PHASE2","title":"A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-03","conditions":"Castration-Resistant Prostatic Cancer, Metastasis","enrollment":360},{"nctId":"NCT05072314","phase":"PHASE3","title":"Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial","status":"RECRUITING","sponsor":"Monash University","startDate":"2022-07-27","conditions":"Breast Cancer, Breast Cancer Female, Breast Conserving Surgery","enrollment":4300},{"nctId":"NCT07493408","phase":"PHASE2","title":"Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-03-30","conditions":"Ph+ Acute Lymphoblastic Leukemia (Ph+ALL), Blastic Transformation of Chronic Myeloid Leukemia, Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)","enrollment":45},{"nctId":"NCT07130357","phase":"NA","title":"The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-12-25","conditions":"Achilles Tendon Rupture","enrollment":48},{"nctId":"NCT07476937","phase":"NA","title":"Differences in Rest, Emotion, and Arousal Modulation in Youth","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-04","conditions":"Autism, Sleep Disturbances in Children, Sleep","enrollment":60},{"nctId":"NCT07492238","phase":"NA","title":"Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cancer Conversion Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xiujuan Qu","startDate":"2025-03-20","conditions":"Colorectal Cancer","enrollment":120},{"nctId":"NCT06678425","phase":"NA","title":"This Study is About the Efficacy of Repetitive Peripheral Magnetic Stimulation on the Treatment of Shoulder Subluxation in Subacute Stroke Patients.","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2025-01-01","conditions":"Shoulder Subluxation, Subacute Stroke, Magnetic Stimulation","enrollment":20},{"nctId":"NCT07384364","phase":"","title":"Observational Study Evaluating Robotic Spinal Mobilization in 16 Parkinson's Disease Participants. The Study Recorded Changes in Mobility, Sit-to-stand Performance, and Pain Scores After a 2-week Intervention With the BackHug Device.","status":"COMPLETED","sponsor":"Pacla Medical Limited","startDate":"2025-09-24","conditions":"Parkinson's Disease (PD)","enrollment":19},{"nctId":"NCT07492732","phase":"","title":"Comparison of the Effects of Selected Training Methods and SIS Stimulation on Balance, Motor Tests, and Strength","status":"RECRUITING","sponsor":"Gdansk University of Physical Education and Sport","startDate":"2025-03-15","conditions":"Hamstring Injury","enrollment":30},{"nctId":"NCT07219797","phase":"NA","title":"Study of Monochromatic X-ray Mammography System","status":"NOT_YET_RECRUITING","sponsor":"Imagine Scientific, Inc.","startDate":"2026-06","conditions":"Breast Imaging, Breast Cancer","enrollment":52},{"nctId":"NCT07492342","phase":"PHASE2","title":"Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC","status":"RECRUITING","sponsor":"Jianxing He","startDate":"2026-01-29","conditions":"Resectable NSCLC, KRAS G12C Mutation, Stage IB-IIIA NSCLC","enrollment":30},{"nctId":"NCT07493304","phase":"PHASE3","title":"Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers","status":"NOT_YET_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-04-07","conditions":"Venous Thromboembolism (VTE)","enrollment":1600},{"nctId":"NCT04107727","phase":"PHASE2","title":"Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"PETHEMA Foundation","startDate":"2019-09-05","conditions":"Acute Myeloid Leukemia","enrollment":273},{"nctId":"NCT06926868","phase":"PHASE2, PHASE3","title":"A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-09-11","conditions":"Breast Neoplasms","enrollment":500},{"nctId":"NCT01385176","phase":"NA","title":"Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2011-09-21","conditions":"Heart Failure, Congestive Heart Failure","enrollment":118},{"nctId":"NCT06353386","phase":"PHASE1, PHASE2","title":"Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-05-20","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":220},{"nctId":"NCT06217302","phase":"PHASE3","title":"Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Alessandro Doria","startDate":"2024-10-31","conditions":"Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1","enrollment":150},{"nctId":"NCT03899155","phase":"PHASE2","title":"Pan Tumor Rollover Study","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2019-08-09","conditions":"Cancer","enrollment":1500},{"nctId":"NCT06465069","phase":"PHASE1","title":"A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-07-01","conditions":"Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor","enrollment":420},{"nctId":"NCT06985485","phase":"PHASE2","title":"Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-05-17","conditions":"Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab","enrollment":26},{"nctId":"NCT07491783","phase":"PHASE2","title":"Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Enray Pharmaceutical Sciences Company","startDate":"2026-03-27","conditions":"HNSCC, Soft Tissue Cancer","enrollment":52},{"nctId":"NCT07276958","phase":"PHASE1","title":"A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2026-02-04","conditions":"Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis","enrollment":63},{"nctId":"NCT07488065","phase":"PHASE1","title":"A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","startDate":"2026-03-25","conditions":"Atopic Dermatitis","enrollment":90},{"nctId":"NCT06713798","phase":"PHASE2","title":"Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures","status":"WITHDRAWN","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2025-01-30","conditions":"Metastatic Cancer Lung, Advanced Lung Cancer, CBNPC Cancer","enrollment":""},{"nctId":"NCT05408494","phase":"NA","title":"Engaging Men in Weight Loss With a Game-based mHealth and Neurotraining Program","status":"ACTIVE_NOT_RECRUITING","sponsor":"Drexel University","startDate":"2023-09-01","conditions":"Obesity, Weight Loss","enrollment":228},{"nctId":"NCT07235059","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-11-20","conditions":"Chronic Kidney Disease","enrollment":112},{"nctId":"NCT05614739","phase":"PHASE1","title":"FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2023-01-12","conditions":"Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms","enrollment":535},{"nctId":"NCT06690151","phase":"","title":"Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-02-28","conditions":"Heart Disease Congenital, Neurodevelopmental Disorder","enrollment":450},{"nctId":"NCT07114601","phase":"PHASE1","title":"A Study of LY4257496 in Participants With Cancer (OMNIRAY)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-08-06","conditions":"Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm","enrollment":421},{"nctId":"NCT06788548","phase":"NA","title":"Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-02-03","conditions":"Early Gastric Cancer","enrollment":312},{"nctId":"NCT07024823","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-09","conditions":"Chronic Kidney Disease","enrollment":124},{"nctId":"NCT07226843","phase":"PHASE1","title":"A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers","status":"NOT_YET_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2026-02","conditions":"Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma","enrollment":360},{"nctId":"NCT06276634","phase":"NA","title":"Intermittent Hypoxia in Persons With Multiple Sclerosis","status":"RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2024-04-30","conditions":"Multiple Sclerosis, Multiple Sclerosis-Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive","enrollment":21},{"nctId":"NCT07484958","phase":"","title":"Co-designing a Stroke Rehabilitation Trial Toolkit","status":"ENROLLING_BY_INVITATION","sponsor":"University of Plymouth","startDate":"2026-02-26","conditions":"Stroke, Rehabilitation, Co-design","enrollment":38},{"nctId":"NCT07213791","phase":"PHASE1","title":"A Study of LY4337713 in Participants With FAP-Positive Solid Tumors","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-10-22","conditions":"Ovarian Neoplasms, Breast Neoplasms, Pancreatic Intraductal Neoplasms","enrollment":241},{"nctId":"NCT07484568","phase":"NA","title":"Circuit Training With and Without Upper and Lower Limb Resistance Training in Post-CABG Patients","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2025-07-05","conditions":"Dyspnea, Paroxysmal","enrollment":60},{"nctId":"NCT05267665","phase":"NA","title":"Family Involvement in Treatment for PTSD (FIT-PTSD): A Brief, Feasible Method for Enhancing Outcomes, Retention, and Engagement","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-07-01","conditions":"Posttraumatic Stress Disorder","enrollment":200},{"nctId":"NCT05168982","phase":"","title":"Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2021-08-01","conditions":"Liver Fibrosis","enrollment":200},{"nctId":"NCT07443813","phase":"NA","title":"An Innovative App-based Intervention to Promote Social Connectedness and Well-being in Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Padova","startDate":"2025-11-22","conditions":"Social Isolation in Older Adults, Loneliness","enrollment":100},{"nctId":"NCT04881838","phase":"PHASE3","title":"CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2021-03-01","conditions":"Pediatric Anaplastic Large Cell Lymphoma","enrollment":172},{"nctId":"NCT04591951","phase":"NA","title":"Family Navigation to Improve ADHD Treatment Adherence for Minority Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-05-14","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":108},{"nctId":"NCT06475560","phase":"NA","title":"Camera Capsule Endoscopy in the Routine Diagnostic Pathway for Colorectal Diseases","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-11-27","conditions":"Colorectal Cancer","enrollment":800},{"nctId":"NCT06995820","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-06","conditions":"Healthy","enrollment":136},{"nctId":"NCT07392372","phase":"PHASE1","title":"A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-09","conditions":"HIV -1 Infection","enrollment":61},{"nctId":"NCT07457749","phase":"EARLY_PHASE1","title":"Clinical Performance of a Novel Self-cured Resin Composite Compared to a Light-cured Bioactive Resin Composite Restoration in Proximal Cavities of Posterior Teeth","status":"RECRUITING","sponsor":"British University In Egypt","startDate":"2026-02-18","conditions":"Proximal Cavities of Posterior Teeth","enrollment":50},{"nctId":"NCT07481903","phase":"NA","title":"Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2026-04","conditions":"Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia","enrollment":228},{"nctId":"NCT07294729","phase":"NA","title":"Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medipol University","startDate":"2025-12-25","conditions":"Rotator Cuff Syndrome, Rotator Cuff Injuries","enrollment":45},{"nctId":"NCT04181788","phase":"PHASE1, PHASE2","title":"Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2020-03-18","conditions":"Advanced Malignancies, Non-small-cell Lung Cancer","enrollment":155},{"nctId":"NCT04058990","phase":"NA","title":"Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2019-12-12","conditions":"Coronary Artery Disease","enrollment":180},{"nctId":"NCT04657068","phase":"PHASE1, PHASE2","title":"A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Artios Pharma Ltd","startDate":"2021-01-27","conditions":"Advanced Cancer, Metastatic Cancer, Ovarian Cancer","enrollment":442},{"nctId":"NCT07310901","phase":"PHASE1","title":"A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity","status":"RECRUITING","sponsor":"Corbus Pharmaceuticals Inc.","startDate":"2025-12-04","conditions":"Obese But Otherwise Healthy Participants","enrollment":252},{"nctId":"NCT06664502","phase":"PHASE1, PHASE2","title":"A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration","status":"ACTIVE_NOT_RECRUITING","sponsor":"EyeBiotech Ltd.","startDate":"2024-11-12","conditions":"Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD), BRVO - Branch Retinal Vein Occlusion","enrollment":38},{"nctId":"NCT05548530","phase":"","title":"Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage","status":"RECRUITING","sponsor":"The Affiliated Hospital Of Guizhou Medical University","startDate":"2014-01-01","conditions":"Brain Hemorrhage","enrollment":1000},{"nctId":"NCT05727189","phase":"PHASE1","title":"A Study of Idazoxan in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terran Biosciences Australia Pty Ltd","startDate":"2023-02-14","conditions":"Healthy","enrollment":150},{"nctId":"NCT05101070","phase":"PHASE1, PHASE2","title":"S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Shionogi","startDate":"2022-05-30","conditions":"Solid Tumors","enrollment":282},{"nctId":"NCT05552092","phase":"NA","title":"Optimal Depth for Esophageal Stethoscope","status":"RECRUITING","sponsor":"Chosun University Hospital","startDate":"2022-11-26","conditions":"Surgery","enrollment":40},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT07277127","phase":"NA","title":"Effect of Percutaneous Electrolysis Combined With Exercise on Pain and Function in Chronic Lateral Epicondylitis","status":"COMPLETED","sponsor":"Sivas State Hospital","startDate":"2025-09-05","conditions":"Lateral Epicondylitis","enrollment":68},{"nctId":"NCT06562907","phase":"PHASE1","title":"Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-28","conditions":"Weight Management","enrollment":134},{"nctId":"NCT07458282","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-10","conditions":"Laparoscopic Surgery, Liposomal Bupivacaine, Transversus Abdominis Plane Block","enrollment":318},{"nctId":"NCT06879041","phase":"PHASE1","title":"A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-10","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":95},{"nctId":"NCT07458295","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-10","conditions":"Laparoscopic Surgery, Gynecologic Oncology Patient, Liposomal Bupivacaine","enrollment":110},{"nctId":"NCT07315074","phase":"NA","title":"Effect of Esketamine on Postoperative Sleep in Postmenopausal Women","status":"NOT_YET_RECRUITING","sponsor":"Zhuan Zhang","startDate":"2026-03-01","conditions":"Circadian Rhythm, Postoperative Sleep Disturbance","enrollment":164},{"nctId":"NCT07477938","phase":"NA","title":"A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability","status":"NOT_YET_RECRUITING","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2026-05-01","conditions":"Cancer Awareness and Prevention Education, Breast Cancer Awareness, Intellectual Disabilities (F70-F79)","enrollment":25},{"nctId":"NCT05397496","phase":"PHASE1","title":"Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-10-03","conditions":"B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)","enrollment":61},{"nctId":"NCT03232931","phase":"NA","title":"Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-10-29","conditions":"Preterm Infant","enrollment":248},{"nctId":"NCT07458256","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-10","conditions":"Laparoscopic Surgery, Liposomal Bupivacaine, Local Infiltration","enrollment":190},{"nctId":"NCT05663866","phase":"PHASE2","title":"Premedication to Reduce Amivantamab Associated Infusion Related Reactions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-05-18","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":68},{"nctId":"NCT07473245","phase":"NA","title":"Educational Models for Tobacco Exposure Awareness","status":"NOT_YET_RECRUITING","sponsor":"Karabuk University","startDate":"2026-03-15","conditions":"Passive Smoking, Tobacco Smoke Pollution, Health Education","enrollment":116},{"nctId":"NCT05309785","phase":"PHASE4","title":"Safety and Efficacy of Canagliflozin in Advanced CKD","status":"ACTIVE_NOT_RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2022-11-24","conditions":"ESRD, CKD Stage 4, CKD Stage 5","enrollment":35},{"nctId":"NCT07466940","phase":"PHASE1","title":"A Clinical Study to Evaluate SM17 in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"SinoMab BioScience Ltd","startDate":"2025-10-14","conditions":"Atopic Dermatitis, Asthma, Inflammatory Bowel Disease","enrollment":30},{"nctId":"NCT07475481","phase":"NA","title":"Exercise-Based Strategies for Chronic Back Pain","status":"NOT_YET_RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2027-07-01","conditions":"Chronic Low-back Pain (cLBP)","enrollment":120},{"nctId":"NCT06876233","phase":"NA","title":"Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication","status":"RECRUITING","sponsor":"Chad Stecher@asu.edu","startDate":"2025-09-01","conditions":"Medication Adherence, Hypertension, Habits","enrollment":600},{"nctId":"NCT07472478","phase":"PHASE2","title":"Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-15","conditions":"Lung Cancer (NSCLC), KRAS G12C Lung Cancer","enrollment":32},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT03883217","phase":"NA","title":"Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2021-06-29","conditions":"Parkinson Disease","enrollment":12},{"nctId":"NCT05479045","phase":"PHASE2","title":"A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Georgetown University","startDate":"2026-09","conditions":"Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3","enrollment":24},{"nctId":"NCT07231978","phase":"PHASE1","title":"A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-11-14","conditions":"Healthy","enrollment":72},{"nctId":"NCT06768489","phase":"PHASE1","title":"A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-12-04","conditions":"Multiple Myeloma","enrollment":140},{"nctId":"NCT04936529","phase":"PHASE2","title":"A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-08-02","conditions":"Neuroblastoma","enrollment":286},{"nctId":"NCT07470281","phase":"NA","title":"Oral Mucosa Wound Healing After Gingival Recession Treatment in Diabetic Patients. A Clinical Study.","status":"NOT_YET_RECRUITING","sponsor":"Mauro Santamaria","startDate":"2026-04","conditions":"Diabetes Mellitus, Gingival Recession, Generalized, Gingival Recession, Localized","enrollment":40},{"nctId":"NCT05476497","phase":"PHASE1","title":"Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Allergy Therapeutics","startDate":"2022-10-17","conditions":"Peanut Allergy","enrollment":46}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":73989,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Telixir 10 T2/C10 - CBD 2%, THC 10%","Placebo"],"phase":"marketed","status":"active","brandName":"A2","genericName":"A2","companyName":"Breath of Life International Pharma Ltd","companyId":"breath-of-life-international-pharma-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A2 is a medication that works by inhibiting the reuptake of norepinephrine, serotonin, and dopamine. Used for Major depressive disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}